Nexalin Technology, Inc.

NXL

NASDAQ

Healthcare

Medical - Devices

Houston, TX, US6 employeesnexalin.com

$0.35

-0.00(-1.24%)

Mkt Cap $7M

$0.35

$1.86

52-Week Range

At a Glance

AI-generated

Nexalin Technology, Inc.

Revenue breakdown: Device Sales (40.7%), Equipment (27%), Licensing Fee (25.2%).

$7M

Market Cap

$164.5K

Revenue

-$9M

Net Income

Employees6

Fundamentals

How The Business Makes Money

Revenue by Segment

Device Sales40.7%($191.5K)

Equipment27%($126.9K)

Licensing Fee25.2%($118.6K)

Other7.1%($33.4K)

Revenue by Geography

CN36.9%($275.5K)

International36.9%($275.5K)

US26.1%($194.8K)

Activity

What Changed Recently

Delisting

Jan 22, 2026

. Notice of Delisting of Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 21, 2026, Nexalin Technology, Inc. (the “Compa

Regulation FD

Feb 24, 2026

and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),

Peer Companies

Company	Price	Change	Market Cap	P/E
NRXSNeurAxis, Inc.	$7.21	+0.42%	$81M	-8.5
SCYXSCYNEXIS, Inc.	$0.90	+1.32%	$40M	-4.4
XCURExicure, Inc.	$4.22	+0.96%	$27M	-3.0
ENLVEnlivex Therapeutics Ltd.	$0.98	+1.78%	$24M	-2.1
HBIOHarvard Bioscience, Inc.	$5.16	+1.38%	$23M	-0.4
RVPRetractable Technologies,...	$0.69	+3.29%	$21M	—
IINNInspira Technologies Oxy ...	$0.48	+6.25%	$12M	-2.4
MODDModular Medical, Inc.	$4.98	-7.43%	$11M	-0.4

Analyst View

Company Profile

CIK0001527352

ISINUS65345B2016

CUSIP65345B201

Phone713 660 1100

Address1776 Yorktown, Houston, TX, 77056, US

SEC EDGAR